• 1
    Barker DJ, Eriksson JG, Forsén T, Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 2002; 31: 235239.
  • 2
    Morgan SC, Relaix F, Sandell LL, Loeken MR. Oxidative stress during diabetic pregnancy disrupts cardiac neural crest migration and causes outflow tract defects. Birth Defects Res A Clin Mol Teratol 2008; 82: 453463.
  • 3
    Kumar SD, Dheen ST, Tay SS. Maternal diabetes induces congenital heart defects in mice by altering the expression of genes involved in cardiovascular development. Cardiovasc Diabetol 2007; 6: 34.
  • 4
    Casson IF, Clarke CA, Howard CV, McKendrick O, Pennycook S, Pharoah PO, Platt MJ, Stanisstreet M, van Velszen D, Walkinshaw S. Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ 1997; 315: 275278.
  • 5
    Russell NE, Foley M, Kinsley BT, Firth RG, Coffey M, McAuliffe FM. Effect of pregestational diabetes mellitus on fetal cardiac function and structure. Am J Obstet Gynecol 2008; 199: 312.e17.
  • 6
    Baschat AA. Examination of the fetal cardiovascular system. Semin Fetal Neonatal Med 2010; 16: 212.
  • 7
    Huggon IC, Turan O, Allan LD. Doppler assessment of cardiac function at 11–14 weeks' gestation in fetuses with normal and increased nuchal translucency. Ultrasound Obstet Gynecol 2004; 24: 390398.
  • 8
    Rizzo G, Arduini D, Capponi A, Romanini C. Cardiac and venous blood flow in fetuses of insulin-dependent diabetic mothers: evidence of abnormal hemodynamics in early gestation. Am J Obstet Gynecol 1995; 173: 17751781.
  • 9
    Falcon O, Auer M, Gerovassili A, Spencer K, Nicolaides KH. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks. Ultrasound Obstet Gynecol 2006; 195: 109114.
  • 10
    Turan S, Turan OM, Ty-Torredes K, Harman CR, Baschat AA. Standardization of the first-trimester fetal cardiac examination using spatiotemporal image correlation with tomographic ultrasound and color Doppler imaging. Ultrasound Obstet Gynecol 2009; 33: 652656.
  • 11
    Baschat AA, Harman CR. Venous Doppler in the assessment of fetal cardiovascular status. Curr Opin Obstet Gynecol 2006; 18: 156163.
  • 12
    Russell N, McAuliffe FM. First trimester fetal cardiac function. J Ultrasound Med 2008; 27: 379383.
  • 13
    Hernandez-Andrade E, Figueroa-Diesel H, Kottman C, Illanes S, Arraztoa J, Acosta-Rojas R, Gratacós E. Gestational-age-adjusted reference values for the modified myocardial performance index for evaluation of fetal left cardiac function. Ultrasound Obstet Gynecol 2007; 29: 321325.
  • 14
    Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1(8476): 307310.
  • 15
    Lisowski L, Verheijen P, De Smedt M. Altered fetal circulation in type-1 diabetic pregnancies. Ultrasound Obstet Gynecol 2003; 22: 365369.
  • 16
    Rizzo G, Pietropolli A, Capponi A, Cacciatore C, Arduini D, Romanini C. Analysis of factors influencing ventricular filling patterns in fetuses of type I diabetic mothers. J Perinat Med 1994; 22: 149157.
  • 17
    Hatém MA, Zielinsky P, Hatém DM, Nicoloso LH, Manica JL, Piccoli AL, Zanettini J, Oliveira V, Scarpa F, Petracco R. Assessment of diastolic ventricular function in fetuses of diabetic mothers using tissue Doppler. Cardiol Young 2008; 18: 297302.
  • 18
    Weber HS, Copel JA, Reece EA, Green J, Kleinman CS. Cardiac growth in fetuses of diabetic mothers with good metabolic control. J Pediatr 1991; 118: 103107.
  • 19
    Gandhi JA, Zhang XY, Maidman JE. Fetal cardiac hypertrophy and cardiac function in diabetic pregnancies. Am J Obstet Gynecol 1995; 173: 11321136.
  • 20
    Rizzo G, Arduini D, Romanini C. Accelerated cardiac growth and abnormal cardiac flow in fetuses of type I diabetic mothers. Obstet Gynecol 1992; 80: 369376.
  • 21
    Macklon NS, Hop WC, Wladimiroff JW. Fetal cardiac function and septal thickness in diabetic pregnancy: a controlled observational and reproducibility study. Br J Obstet Gynaecol 1998; 105: 661666.
  • 22
    Ullmo S, Vial Y, Di Bernardo S, Roth-Kleiner M, Mivelaz Y, Sekarski N, Ruiz J, Meijboom EJ. Pathologic ventricular hypertrophy in the offspring of diabetic mothers: a retrospective study. Eur Heart J 2006; 28: 13191325.
  • 23
    Kirby LM. Neural crest, great arteries, and outflow septation, In Cardiac development, KirbyLM (ed.). Oxford, University Press: New York, NY, 2007; 143159.
  • 24
    Leatherbury L, Braden DS, Tomita H, Gauldin HE, Jackson WF. Hemodynamic changes. Wall stresses and pressure gradients in neural crest-ablated chick embryos. Ann N Y Acad Sci 1990; 588: 305313.
  • 25
    Farrell MJ, Kirby ML. Cell biology of cardiac development. Int Rev Cytol 2001; 202: 99158.
  • 26
    Farrell MJ, Burch JL, Wallis K, Rowley L, Kumiski D, Stadt H, Godt RE, Creazzo TL, Kirby ML. FGF-8 in the ventral pharynx alters development of myocardial calcium transients after neural crest ablation. J Clin Invest 2001; 107: 15091517.
  • 27
    Gurjarpadhye A, Hewett KW, Justus C, Wen X, Stadt H, Kirby ML, Sedmera D, Gourdie RG. Cardiac neural crest ablation inhibits compaction and electrical function of conduction system bundles. Am J Physiol Heart Circ Physiol 2007; 292: H1291H1300.
  • 28
    Dyer LA, Kirby ML. The role of secondary heart field in cardiac development. Dev Biol 2009; 336: 137144.
  • 29
    Baschat AA. Development of the fetal cardiac and extracardiac Doppler flows in early gestation. Fetal Cardiology, YagelS, SilvermanNH, GembruchU (eds). Martin Dunitz, Taylor and Francis Group: London, UK, 2003; 121139.
  • 30
    Conway SJ, Godt RE, Hatcher CJ, Leatherbury L, Zolotouchnikov VV, Brotto MA, Copp AJ, Kirby ML, Creazzo TL. Neural crest is involved in development of abnormal myocardial function. J Mol Cell Cardiol 1997; 29: 26752685.